The
risk
of
'zoonotic
spillovers,'
or
the
transmission
viruses
from
animals
to
humans,
has
been
raised
by
climate
change
and
devastation
nature,
as
infectious
disease
experts
have
long
warned.
Even
world
works
stop
spread
currently
unfolding
pandemic
coronavirus
2019
(COVID-19)
breakout
monkeypox
virus
(MPXV),
a
new
animal
virus,
Langya
henipavirus
(LayV),
discovered
in
humans
Eastern
China.
scientists
say
there
is
little
danger
spreading
among
but
it
shares
genetic
material
with
Hendra
Nipah
two
other
henipaviruses
that
infect
cause
life-threatening
respiratory
diseases.
Humans
infected
LayV
can
expect
experience
high
body
temperature,
cough,
weariness,
poor
appetite,
muscle
discomfort,
myalgia,
nausea
vomiting.
It
likely
will
humans.
Currently,
health
authorities
Taiwan
organizations
are
tracking
progress
ailment
ensure
does
not
reach
Researchers
examined
25
species
small
wild
for
presence
so
far,
shrews
only
ones
tested
positive
virus's
RNA.
Based
on
these
results,
possible
candidate
natural
reservoir.
Too
no
therapies
vaccines
developed
licensed
like
LayV.
When
fail
alleviate
viral
infections,
ribavirin
may
be
next
best
thing.
need
novel
vaccinations
against
infection
timely
delivery
areas
at
epidemiological
real.
To
lessen
likelihood
calamity
being
caused
this
newly
developing
crucial
conduct
active
surveillance
transparent
globally
collaborative
manner.
questions
answered
yet
require
additional
study.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(6), P. e17376 - e17376
Published: June 1, 2023
In
July
2022,
a
new
virus
called
Langya
(LayV)
was
discovered
in
China
patients
who
had
fever.
This
is
type
of
Henipavirus
(HNV)
and
considered
potential
threat
as
it
could
spread
from
animals
to
humans.
It
causes
respiratory
disease
with
symptoms
including
fever,
coughing,
fatigue
closely
linked
two
other
henipaviruses
that
are
known
infect
humans,
namely
Hendra
Nipah
viruses.
These
viruses
may
cause
fatal
illnesses.
Investigators
believe
the
LayV
by
shrews,
have
infected
humans
directly
or
via
an
intermediary
species.
Thus,
use
vaccines
immunizations
against
alternate
strategy
for
prevention.
this
study,
we
employed
various
immunoinformatics
methods
predict
B
cell,
HTL
T
cell
epitopes
proteome
order
find
most
promising
candidate
vaccine.
The
potent
immunogenic
non-allergenic
were
joined
each
through
suitable
linkers.
Human
β-defensin
2
adjuvant
increase
immunogenicity
vaccine
construct.
final
sequence
multi-epitope
construct
modelled
docking
TLRs.
Concisely,
our
results
suggest
docked
complexes
vaccine-TLRs
seemed
be
stable.
Additionally,
silico
cloning
done
using
E.
coli
host
validate
expression
designed
GC
content
54.39%
CAI
value
0.94
revealed
component
expresses
efficiently
host.
study
presents
novel
which
will
essential
further
experimental
validations
confirm
safety
proposed
structure,
eventually
treat
HNV-related
diseases.
International Journal of Surgery,
Journal Year:
2023,
Volume and Issue:
109(2), P. 163 - 164
Published: Jan. 23, 2023
Highlights
Langya
virus
is
a
Henipavirus
that
has
been
found
in
shrews,
bats,
and
rats.
The
virus's
origin
still
unknown.
Henipaviruses
do
not
have
any
approved
therapies.
There
currently
no
evidence
the
may
spread
from
human
to
human.
Dear
Editor,
rats,
other
small
animals.
Some
studies
also
reveal
animals
such
as
dogs
goats
natural
antibodies
virus1.
Furthermore,
when
exposed
bat
urine,
species
horses
or
infect
pigs2.
As
member
of
RNA
family
Paramyxoviridae,
henipavirus
(LayV)
evolutionary
ties
with
Nipah
Hendra
virus3.
Both
viruses
are
emerging
zoonotic
diseases
Asia-Pacific
area.
Despite
their
differences,
these
two
antigenic,
serological,
ultrastructural
features
place
them
same
genus4.
On
4
August,
it
was
initially
reported
New
England
Journal
Medicine.
Thirty-five
persons
China's
Shandong
Henan
provinces
contracted
LayV
between
December
2018
May
20215.
This
indicates
spreading
among
humans
readily.
clusters
instances
within
family,
like
what
happen
coronavirus
disease
2019,
short
amount
time
close
proximity
one
another4,6.
Contact
tracing
performed
on
nine
affected
persons,
after
contacting
15
contacts
each
patient,
researchers
infection7.
finding
lends
credence
theory
transmitted
person
but
animal
To
needs
great
deal
effort
direct
physical
contact.
People
fever
eastern
China
who
had
just
led
discovery
virus.
In
absence
cure,
problems
be
treated
supportive
care.
Scientists
investigated
different
for
presence
determine
origins
infection.
They
discovered
viral
dogs,
shrew
principal
source
27%
samples8.
However,
most
likely
passed
Because
identified
mostly
they
its
hosts9.
contagiousness
determined
by
spreadability
contagiousness.
facts
about
human-to-human
transfer.
scholars
assert
investigation's
sample
size
too
detect
transmission.
Conversely,
close-contact
transmission
tracking
patients
relatives2.
Those
infected
following
symptoms:
fever,
fatigue,
cough,
anorexia,
myalgia,
nausea,
headache,
vomiting.
35%
those
contaminated
impaired
liver
function,
8%
renal
function.
According
doctors,
might
cause
decrease
number
platelets
blood,
significant
damage
kidneys
liver,
possibly
death5.
produce
symptoms
appetite
decrease,
muscle
cramps,
Serum
seropositivity
2%
5%
domestic
animals10.
Since
identification
this
strain
novel,
serves
illustrate
ever-present
danger
creation
(new)
infections.
Due
size,
further
work
needed
fully
grasp
disease's
epidemiological
microbiological
features.
When
comes
combating
potential
pandemic
infections,
essence,
making
surveillance
development
crucial
tool.
experiments,
experts
only
tested
few
antiviral
alternatives.
particular
vaccination
ribavirin
an
effective
therapy.
Doctors
often
use
medicine
treat
infections
therapeutic
options.
Ribavirin
against
viruses,
including
respiratory
problems.
Studies
demonstrate
both
viruses.
malaria
chloroquine
useful
treating
conditions1,11.
result,
if
necessary,
medications
aid
control
unusual
poorly
understood,
predict
verified
cases
will
rise.
More
study
required
entire
scope,
mode
dissemination,
whether
already
reached
surrounding
region.
Ethical
approval
Not
applicable.
Conflicts
interest
disclosure
conflicts
interest.
Sources
funding
No
received.
Author
contribution
R.A.:
conceptualization,
data
curation,
writing
–
original
draft
preparation,
reviewing,
editing.
R.D.
H.C.:
T.B.E.:
reviewing
editing,
visualization,
supervision.
Research
registration
unique
identifying
(UIN)
1.
Name
registry:
2.
Unique
ID:
3.
Hyperlink
your
specific
(must
publicly
accessible
checked):
Guarantor
Talha
Bin
Emran,
PhD,
Associate
Professor,
Department
Pharmacy,
BGC
Trust
University
Bangladesh,
Chittagong
4381,
Bangladesh.
Tel:
+880
303
356
193,
fax:
312
550
224.
https://orcid.org/0000-0003-3188-2272
Provenance
peer
review
commissioned,
internally
peer-reviewed.
Data
statement
correspondence
article
sensitive
nature
public
domain.
therefore
available
confidential
nature.
Animals,
Journal Year:
2023,
Volume and Issue:
14(1), P. 88 - 88
Published: Dec. 26, 2023
Chiroptera
are
one
of
the
most
diverse
mammal
orders.
They
considered
reservoirs
main
human
pathogens,
where
coronaviruses
(CoVs)
and
paramyxoviruses
(PMVs)
may
be
highlighted.
Moreover,
growing
number
publications
on
CoVs
PMVs
in
wildlife
reinforces
scientific
community’s
interest
eco-vigilance,
especially
because
emergence
important
pathogens
such
as
SARS-CoV-2
Nipha
viruses.
Considering
that
Brazil
presents
continental
dimensions,
is
biologically
rich
containing
biotas
a
biodiversity
animals
classified
order
Chiroptera,
mapping
CoV
PMV
genetics
related
to
aim
present
work.
can
into
four
genera:
Alphacoronavirus,
Betacoronavirus,
Deltacoronavirus
Gammacoronavirus.
Delta-
gammacoronaviruses
infect
mainly
birds,
while
alpha-
betacoronaviruses
contain
animal
pathogens.
Almost
60%
bats,
which
natural
hosts
these
viral
genera
members.
The
studies
presence
bats
from
have
assayed
phyllostomid,
molossid
vespertilionid
South,
Southeast
North
territories.
Despite
not
hosting
rhinophilid
or
pteropodid
SARS-related
henipaviruses,
respectively,
reported
Brazilian
genetically
closely
some
Most
works
performed
with
alpha-CoVs
were
other
bat-CoVs,
despite
few
reports
beta-CoVs
grouped
Merbecovirus
Embecovirus
subgenera.
family
Paramyxoviridae
includes
subfamilies
(Avulavirinae,
Metaparamyxovirinae,
Orthoparamyxovirinae
Rubulavirinae),
significant
drivers
cross-species
transmission.
Additionally,
evaluated
found
sequences
Jeilongvirus
Morbillivirus
belong
subfamily.
increasing
amount
research
analyzing
samples
still
scarce.
When
surveying
representativeness
available
genomic
sequences,
it
perceived
there
gaps
knowledge.
continuous
monitoring
helpful
predicting
future
hotspots
zoonotic
agents.
Molecular Simulation,
Journal Year:
2024,
Volume and Issue:
50(15), P. 1170 - 1182
Published: Aug. 13, 2024
Outbreaks
of
human
Nipah
virus
(NiV)
cases
have
recently
been
reported
in
several
countries.
With
a
mortality
rate
around
80%
and
no
known
therapy,
there
is
an
urgent
need
to
test
existing
antivirals
repurposed
for
it.
Due
its
central
role
replication,
the
RNA-dependent
RNA
polymerase
(RdRp)
NiV-L
protein
potential
target
such
antiviral
therapies.
In
this
study,
Favipiravir,
Remdesivir,
Ribavirin,
their
metabolites,
including
monophosphate
(MP),
diphosphate
(DP),
triphosphate
(TP),
were
virtually
screened
against
RdRp.
Using
molecular
dynamics
(MD)
simulations,
lead
hits
from
docking
study
examined
conformational
changes.
Additional
analyses,
MM-PBSA,
residual
decomposition
energy,
principal
component
analysis,
performed
on
MD
trajectory.
Remdesivir-TP,
Favipiravir-TP,
Ribavirin-TP
exhibited
lowest
binding
energies
–7.8,
−7.4,
−6.9
kcal/mol,
respectively,
displayed
affinity
pocket
1,
forming
interactions
with
active
site
residues
Asp726
Asn727.
During
100
ns
simulation,
Remdesivir-TP
demonstrated
more
stable
mode
compared
Favipiravir-TP
Ribavirin-TP.
The
relative
−94.709
kJ/mol,
−68.882
−46.98
kJ/mol
Ribavirin-TP,
respectively.
This
research
anticipates
be
candidate
drug
NiV
infection.
Zoonoses,
Journal Year:
2023,
Volume and Issue:
3(1)
Published: Jan. 1, 2023
Vaccines
are
the
most
promising
tools
for
maintaining
public
health.
Most
emerging
human
infectious
diseases
caused
by
viruses
originating
from
an
animal
reservoir
via
zoonotic
transmission.
Therefore,
virus
spillover
and
spread
in
humans
have
become
global
health
threats.
Nanoparticle-based
vaccines
ideal
antigen
delivery,
as
adjuvants,
viral
structure
mimics.
Nanoparticles
benefit
vaccine
design
utilized
to
protect
cargo,
increase
immunogenicity
efficacy.
nanoparticle
a
novel
method
of
immunization
which
optimal
immune
responses
elicited.
Herein
we
review
current
approaches
development
highlight
role
against
diseases.
Cell Insight,
Journal Year:
2024,
Volume and Issue:
3(4), P. 100181 - 100181
Published: July 2, 2024
Nipah
Virus
(NiV)
and
Hendra
(HeV),
are
the
prototype
species
of
genus
Henipavirus
highly
pathogenic
agents
capable
causing
fatal
diseases
in
both
animals
humans.
Both
NiV
HeV
classified
as
biosafety
level-4
(BSL-4)
restricted
pathogens
remain
only
henipaviruses
within
known
to
cause
systemic,
severe
respiratory
encephalitic
henipaviral
disease,
represent
substantial
transboundary
threats.
There
no
approved
prophylactic
or
therapeutic
treatments
for
human
henipavirus
infections,
World
Health
Organization
acknowledges
them
priority
needing
urgent
research.
The
discovery
Cedar
virus
(CedV),
recognized
non-pathogenic
henipavirus,
has
provided
a
number
unique
opportunities
study
host
interactions
also
facilitate
countermeasure
development
research
at
lower
BSL-2
containment.
This
review
will
highlight
aspects
CedV
biology
how
it
been
exploited
model
developing
strategies
against
more
virulent
species.